ARMATA PHARMACEUTICALS, INC. (ARMP) Free cash flow 2016–2025
ARMATA PHARMACEUTICALS, INC. (ARMP) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$26.3MFY2025 · since FY2016: -$10.9M → -$26.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$26.3M | +33.3% |
| FY2024 | -$39.4M | +29.0% |
| FY2023 | -$55.6M | -60.2% |
| FY2022 | -$34.7M | -39.4% |
| FY2021 | -$24.9M | -30.3% |
| FY2020 | -$19.1M | -20.8% |
| FY2019 | -$15.8M | -37.4% |
| FY2018 | -$11.5M | -24.3% |
| FY2017 | -$9.3M | +15.0% |
| FY2016 | -$10.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice